Literature DB >> 15892986

Enhanced serum cholesterol and triglyceride levels in bulimia nervosa: relationships to psychiatric comorbidity, psychopathology and hormonal variables.

Palmiero Monteleone1, Paolo Santonastaso, Marilena Pannuto, Angela Favaro, Lorenza Caregaro, Eloisa Castaldo, Tatiana Zanetti, Mario Maj.   

Abstract

Increased levels of cholesterol have been reported in patients with bulimia nervosa (BN), but all but one of the published studies were performed on non-fasting subjects, which limits the interpretation of this finding. Moreover, the relationships between serum lipids and comorbid psychiatric disorders or bulimic psychopathology have scarcely been investigated. We measured serum levels of total cholesterol, triglycerides, glucose, 17beta-estradiol and thyroid hormones in 75 bulimic women and 64 age-matched healthy females after an overnight fast. Compared with healthy women, bulimic patients exhibited significantly enhanced serum levels of cholesterol and triglycerides, but similar values of glucose, 17beta-estradiol, FT3 and FT4. No significant differences emerged in these variables between patients with or without comorbid depression, borderline personality disorder or lifetime anorexia nervosa. Circulating cholesterol was positively correlated to the patients' drive for thinness, ineffectiveness, enteroceptive awareness and impulse regulation sub-item scores of the Eating Disorder Inventory-2. These findings confirm that BN is associated with increased levels of serum lipids. This alteration may be involved in the pathophysiology of certain psychopathological characteristics of BN and cannot be explained by the co-occurrence of other psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15892986     DOI: 10.1016/j.psychres.2004.06.019

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  6 in total

1.  Association of Bulimia Nervosa With Long-term Risk of Cardiovascular Disease and Mortality Among Women.

Authors:  Rasmi M Tith; Gilles Paradis; Brian J Potter; Nancy Low; Jessica Healy-Profitós; Siyi He; Nathalie Auger
Journal:  JAMA Psychiatry       Date:  2020-01-01       Impact factor: 21.596

2.  Correlation of BDNF blood levels with interoceptive awareness and maturity fears in anorexia and bulimia nervosa patients.

Authors:  J M Mercader; F Fernández-Aranda; Mònica Gratacòs; Zaida Aguera; Laura Forcano; Marta Ribasés; Cynthia Villarejo; Xavier Estivill
Journal:  J Neural Transm (Vienna)       Date:  2010-03-02       Impact factor: 3.575

3.  Risk factors in autism spectrum disorder: A Tunisian case-control study.

Authors:  Senda Slama; Wael Bahia; Ismael Soltani; Naoufel Gaddour; Salima Ferchichi
Journal:  Saudi J Biol Sci       Date:  2022-01-04       Impact factor: 4.052

4.  Neural changes associated with appetite information processing in schizophrenic patients after 16 weeks of olanzapine treatment.

Authors:  E Stip; O V Lungu; K Anselmo; G Letourneau; A Mendrek; B Stip; O Lipp; P Lalonde; L A Bentaleb
Journal:  Transl Psychiatry       Date:  2012-06-19       Impact factor: 6.222

5.  The PED-t trial protocol: The effect of physical exercise -and dietary therapy compared with cognitive behavior therapy in treatment of bulimia nervosa and binge eating disorder.

Authors:  Therese Fostervold Mathisen; Jan H Rosenvinge; Gunn Pettersen; Oddgeir Friborg; KariAnne Vrabel; Solfrid Bratland-Sanda; Mette Svendsen; Trine Stensrud; Maria Bakland; Rolf Wynn; Jorunn Sundgot-Borgen
Journal:  BMC Psychiatry       Date:  2017-05-12       Impact factor: 3.630

6.  Bilateral Parotid Sialadenosis Associated with Long-Standing Bulimia: A Case Report and Literature Review.

Authors:  Blas Garcia Garcia; Alicia Dean Ferrer; Nelida Diaz Jimenez; Francisco Jesus Alamillos Granados
Journal:  J Maxillofac Oral Surg       Date:  2016-05-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.